Navigation Links
Basic work on E. coli identifies two new keys to regulation of bacterial gene expression

ion in DNA and transcribes it into chains of RNA, which are later translated into proteins. Promoter regions are specific sequences within the DNA chain that tell RNA polymerase when and where to begin transcription, and how much product to make from specific genes.

Gourse's group found that there is a specific region within DNA promoters that makes contact with a highly conserved but previously underappreciated segment of the sigma subunit of RNA polymerase. While the contact with sigma is very strong at promoters for most genes, it is particularly weak at promoters that make ribosomal RNA, which means that other factors like nutritional and environmental signals ultimately regulate the expression of those genes.

"In this case, regulation is achieved not because the promoter makes a special contact, but because it can't establish contact at all," says Gourse. "This is an example of how sometimes less is more, and a probably very ancient example of one of the methods that arose through evolution to regulate gene expression."

Ribosomal RNA makes up the bulk of ribosomes, the molecular machines that make proteins and are present in huge numbers in all cells. Since so much of the cell's energy is used to make ribosomes, control of ribosomal RNA transcription is particularly crucial to a cell's well-being.

"This work is basic to the growth of all bacteria," says Gourse. "By understanding transcription and control of ribosome synthesis in E. coli, we can understand more about these processes in bacterial species that we need to control, like those that cause disease or make toxins. E. coli is also the workhorse of the biotechnology industry. Understanding E. coli gene expression in detail allows us to harness these cells for producing products of biotechnological importance, like pharmaceuticals."

Gourse's work was supported by the National Institutes of Health, the United States Department of Agriculture, and by Pfizer Biotechno
'"/>

Source:University of Wisconsin-Madison


Page: 1 2 3

Related biology news :

1. Distributed Basic Local Alignment Search Toolkit (W.ND-BLAST)
2. Basic research leads to a novel cancer therapy
3. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
4. New lab technique identifies high levels of pathogens in therapy pool
5. Study identifies gene in mice that may control risk-taking behavior in humans
6. Researcher at UGA College of Veterinary Medicine identifies new way of combating viral diseases
7. U. of Colorado researcher identifies tracks of swimming dinosaur in Wyoming
8. Model identifies genes that induce normal skin cells to become abnormal
9. New study identifies key gene in development of connections between brain and spinal cord
10. New HIV study identifies high-risk subgroups of adolescents
11. Research identifies protein in mice that regulates bone formation
Post Your Comments:
(Date:7/31/2014)... cells, are inherently different. Each of these cell types ... in metabolism. In the human body, white adipose tissue ... is energy storage. On the other hand, brown adipocytes ... found in a few places in the adult human ... brown adipocytes, appear mixed with brown adipocytes in human ...
(Date:7/31/2014)... shown that marine noise can affect animal movement and ... of Bristol and Exeter and the cole Pratique des ... boat noise stops embryonic development and increases larval mortality ... slug Stylocheilus striatus used in this study) ... later feed on toxic alga but this study, conducted ...
(Date:7/30/2014)... regulate its genes, and adapt to changes in its ... regulation taking place in the truffle, is published in ... illustrates how the truffle deals with its complex genome,s ... may shed light on how traits like aroma and ... known as Prigord truffles, have a syrupy sweet flavor ...
Breaking Biology News(10 mins):Hope for the overweight 2Boat noise impacts development and survival of sea hares 2How black truffles deal with the jumpers in their genome 2
... The next generation of biometric technology launches today with ... by University of Toronto engineering graduates. The Nymi is ... unique heartbeat to unlock your identity. The convenient and ... sensor. When the Nymi recognizes your personal ECG, it ...
... American Association of Pharmaceutical Scientists (AAPS) ... gather to share the latest groundbreaking scientific discoveries and ... Exposition. ,The event will bring together more than 8,000 ... discuss current initiatives underway aimed at improving global health ...
... The science and engineering capabilities that underpin the ... nation,s three national security laboratories are "healthy and vibrant," ... The committee that wrote the report found no ... would prevent certification of the stockpile. However, the report ...
Cached Biology News:Nymi by Bionym launches using your unique heartbeat to unlock your world 2New report reviews science and engineering quality at national security laboratories 2
(Date:7/30/2014)... , July 30, 2014 Regulus ... biopharmaceutical company leading the discovery and development of innovative ... financial results and highlights for the quarter ended June ... U.S. financial markets close. Regulus will ... 6, 2014, at 5:00 pm Eastern Daylight Time to ...
(Date:7/30/2014)... A study presented at the 2014 ... of CSL Behring,s C1 Inhibitor (C1-INH) concentrate in ... sensitized patients. C1-INH is a human protein and ... The study shows that post-transplant treatment with ... of complement components 3 and 4, suggesting that ...
(Date:7/30/2014)... 30, 2014 Selexis SA , ... drug discovery and mammalian cell line development, announced today ... ™ will be presented at the 10th Annual ... September 8 – 10, 2014 at the Double Tree ... The following abstract will be presented during an oral ...
(Date:7/30/2014)... NY (PRWEB) July 30, 2014 July ... (Twitter: @APDN), a biotechnology firm that provides DNA-based authentication ... E. Hogan, Ph.D. Vice President of Life Sciences, a ... , Dr. Hogan will lead APDN’s drive ... business relationships with biotech and healthcare customers, provide guidance ...
Breaking Biology Technology:Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 3Study Suggests C1-INH May Aid in Prevention of Antibody-Mediated Rejection Following Kidney Transplant 2Study Suggests C1-INH May Aid in Prevention of Antibody-Mediated Rejection Following Kidney Transplant 3Selexis SA to Present New Data and a Case Study at IBC’s Cell Line Development and Engineering Conference 2Selexis SA to Present New Data and a Case Study at IBC’s Cell Line Development and Engineering Conference 3Dr. Michael E. Hogan, Ph.D., Joins Applied DNA Sciences as Vice President, Life Sciences 2Dr. Michael E. Hogan, Ph.D., Joins Applied DNA Sciences as Vice President, Life Sciences 3
... of Spinal Muscular Atrophy SOUTH PLAINFIELD, N.J. and NEW ... the Spinal Muscular Atrophy (SMA) Foundation today announced the ... Foundation will provide up to $8.5 million in funding ... the collaboration to fund a series of research projects ...
... 12 NovImmune, an,immunology-focused biotech company dedicated to ... it has raised CHF,62.5 million (USD 54.8 million) ... and NI-0501, a fully human monoclonal antibody to ... its pipeline.,The transaction was led by BZ Bank ...
... (Nasdaq: VRUS ), a clinical stage pharmaceutical ... to treat viral infections, reported financial results and operational ... Financial Results Revenues were $1.9 million during the ... for the quarter ended March 31, 2008 and reflect ...
Cached Biology Technology:PTC Therapeutics and Spinal Muscular Atrophy Foundation Announce $8.5 Million Small Molecule Development Collaboration 2PTC Therapeutics and Spinal Muscular Atrophy Foundation Announce $8.5 Million Small Molecule Development Collaboration 3NovImmune Completes CHF 62.5 (USD 54.8) Million Equity Financing to Move Portfolio Forward and Reacquire Product Rights to Lead Antibodies 2Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 2Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 3Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 4Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 5Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 6Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 7Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 8
... Immunogen: Recombinant human IDO (Indoleamine-pyrrol ... the ~44 kDa human IDO ... control: IFN-Gamma-stimmulated Human peripheral blood ... reactivity with mouse and rat ...
...
TRIzol Reagents are ready-to-use monophasic solutions of phenol and guanidine isothiocyanate suitable for isolating total RNA DNA and proteins (16)....
... total protein western blot (WtPAN) ... tissue specific protein expression in ... protein is included in each ... for comparison between different western ...
Biology Products: